290 related articles for article (PubMed ID: 2732517)
1. Prevention of pneumococcal bacteremia by immunization with type 6 pneumococcal capsular polysaccharide vaccine in splenectomized rats.
Iinuma H; Okinaga K
J Infect Dis; 1989 Jul; 160(1):66-75. PubMed ID: 2732517
[TBL] [Abstract][Full Text] [Related]
2. Pneumococcal vaccine improves pulmonary clearance of live pneumococci after splenectomy.
Hebert JC
J Surg Res; 1989 Oct; 47(4):283-7. PubMed ID: 2770287
[TBL] [Abstract][Full Text] [Related]
3. The antibody response after immunization with pneumococcal polysaccharide vaccine in splenectomized mice: the effect of re-immunization with pneumococcal antigens.
Aaberge IS; Løvik M
APMIS; 1996 Apr; 104(4):307-17. PubMed ID: 8645471
[TBL] [Abstract][Full Text] [Related]
4. Immune responses of splenectomized trauma patients to the 23-valent pneumococcal polysaccharide vaccine at 1 versus 7 versus 14 days after splenectomy.
Shatz DV; Schinsky MF; Pais LB; Romero-Steiner S; Kirton OC; Carlone GM
J Trauma; 1998 May; 44(5):760-5; discussion 765-6. PubMed ID: 9603075
[TBL] [Abstract][Full Text] [Related]
5. IgM and IgG response to pneumococcal polysaccharide vaccine in normal individuals and individuals splenectomized due to trauma.
Aaberge IS; Heier HE; Hem E; Giercksky KE; Groeng EC
Acta Pathol Microbiol Immunol Scand C; 1984 Feb; 92(1):11-6. PubMed ID: 6711306
[TBL] [Abstract][Full Text] [Related]
6. Antibody responses of splenectomized patients with non-Hodgkin's lymphoma to immunization with polyvalent pneumococcal vaccines.
Petrasch S; Kühnemund O; Reinacher A; Uppenkamp M; Reinert R; Schmiegel W; Lütticken R; Brittinger G
Clin Diagn Lab Immunol; 1997 Nov; 4(6):635-8. PubMed ID: 9384280
[TBL] [Abstract][Full Text] [Related]
7. IgG and IgM antibody responses to pneumococcal vaccination in splenectomized children and in children who had non-operative management of splenic rupture.
Kalin M; Linné T; Eriksson M; Lännergren K; Tordal P; Jakobsson B; Lundmark KM
Acta Paediatr Scand; 1986 May; 75(3):452-6. PubMed ID: 3728005
[TBL] [Abstract][Full Text] [Related]
8. Long-term effect of pneumococcal polysaccharide vaccination on serum IgM and IgG antibody levels in individuals splenectomized for trauma.
Aaberge IS; Heier HE
Acta Pathol Microbiol Immunol Scand C; 1984 Dec; 92(6):363-9. PubMed ID: 6524388
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of antibody responses to pneumococcal vaccines with ELISA and opsonophagocytic assay.
Kim KH; Seoh JY
J Korean Med Sci; 1999 Oct; 14(5):475-9. PubMed ID: 10576141
[TBL] [Abstract][Full Text] [Related]
10. IgG subclass antibody responses to pneumococcal polysaccharide vaccine in splenectomized, otherwise normal, individuals.
Aaberge IS; Michaelsen TE; Heier HE
Scand J Immunol; 1990 Jun; 31(6):711-6. PubMed ID: 2356437
[TBL] [Abstract][Full Text] [Related]
11. Serum antibodies to pneumococcal C polysaccharide in children: response to acute pneumococcal otitis media or to vaccination.
Koskela M
Pediatr Infect Dis J; 1987 Jun; 6(6):519-26. PubMed ID: 3615065
[TBL] [Abstract][Full Text] [Related]
12. Protection from postsplenectomy sepsis: Effect of prophylactic penicillin and pneumococcal vaccine on clearance of type 3 Pneumococcus.
Scher KS; Wroczynski AF; Jones CW
Surgery; 1983 Jun; 93(6):792-7. PubMed ID: 6407133
[TBL] [Abstract][Full Text] [Related]
13. Timing of vaccination does not affect antibody response or survival after pneumococcal challenge in splenectomized rats.
Schreiber MA; Pusateri AE; Veit BC; Smiley RA; Morrison CA; Harris RA
J Trauma; 1998 Oct; 45(4):692-7; discussion 697-9. PubMed ID: 9783606
[TBL] [Abstract][Full Text] [Related]
14. Tamarin model of pneumococcal bacteremia.
Chudwin DS; Artrip SG; Ogden JD; Schiffman G
J Med Primatol; 1987; 16(4):249-60. PubMed ID: 3114496
[TBL] [Abstract][Full Text] [Related]
15. Spleen autotransplantation provides restoration of functional splenic lymphoid compartments and improves the humoral immune response to pneumococcal polysaccharide vaccine.
Leemans R; Harms G; Rijkers GT; Timens W
Clin Exp Immunol; 1999 Sep; 117(3):596-604. PubMed ID: 10469068
[TBL] [Abstract][Full Text] [Related]
16. Serum antibody and opsonic responses to vaccination with pneumococcal capsular polysaccharide in normal and splenectomized children.
Giebink GS; Foker JE; Kim Y; Schiffman G
J Infect Dis; 1980 Mar; 141(3):404-12. PubMed ID: 6988526
[No Abstract] [Full Text] [Related]
17. Active Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae Keratitis.
Norcross EW; Sanders ME; Moore QC; Taylor SD; Tullos NA; Caston RR; Dixon SN; Nahm MH; Burton RL; Thompson H; McDaniel LS; Marquart ME
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):9232-43. PubMed ID: 22039231
[TBL] [Abstract][Full Text] [Related]
18. Opsonic and antibody responses to pneumococcal polysaccharide types 6A, 19F and 23F after vaccination of immunocompromised patients.
Braconier JH; Pedersen FK; Odeberg H; Rosén C
Scand J Infect Dis; 1984; 16(2):161-7. PubMed ID: 6740247
[TBL] [Abstract][Full Text] [Related]
19. Reduction of Streptococcus pneumoniae Colonization and Dissemination by a Nonopsonic Capsular Polysaccharide Antibody.
Doyle CR; Pirofski LA
mBio; 2016 Feb; 7(1):e02260-15. PubMed ID: 26838726
[TBL] [Abstract][Full Text] [Related]
20. L-rhamnose is often an important part of immunodominant epitope for pneumococcal serotype 23F polysaccharide antibodies in human sera immunized with PPV23.
Park S; Nahm MH
PLoS One; 2013; 8(12):e83810. PubMed ID: 24391831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
